CHHHHHHHHHHHHHHINA
7 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Sophie Webb from Pharma in Emerging Markets
Scoop.it!

Top Emerging Pharmaceutical Markets

China's pharmaceutical market received a huge boost from health system reforms instituted by the government between 2009 and 2011.

Via Aleksandra Misiorowska
more...
No comment yet.
Rescooped by Sophie Webb from Chinese Cyber Code Conflict
Scoop.it!

China Growing Hostile, What It Means to Americans | TPE Post

China Growing Hostile, What It Means to Americans | TPE Post | CHHHHHHHHHHHHHHINA | Scoop.it
Courtesy of Lignet What's happening in China right now is downright frightening.

Via Red-DragonRising
more...
No comment yet.
Scooped by Sophie Webb
Scoop.it!

Why Trying to Hurt China in the Trade Game Could Backfire - TIME

Why Trying to Hurt China in the Trade Game Could Backfire - TIME | CHHHHHHHHHHHHHHINA | Scoop.it
Economic Times
Why Trying to Hurt China in the Trade Game Could Backfire
TIME
U.S. trade representative Michael Froman shakes hands with Chinese Vice Premier Wang Yang while U.S.
more...
No comment yet.
Scooped by Sophie Webb
Scoop.it!

GlaxoSmithKline's tussle with China is getting messier and riskier ...

GlaxoSmithKline's tussle with China is getting messier and riskier ... | CHHHHHHHHHHHHHHINA | Scoop.it
The latest twist is the claim by Chinese police to have discovered an organised bribery ring within GSK's local office. The significance of that tale is that – if proved – it would be harder for the company to argue that it is the ...
more...
No comment yet.
Scooped by Sophie Webb
Scoop.it!

GlaxoSmithKline plc (ADR) (GSK): China to release blacklist for corporate bribery - Seeking Alpha

GlaxoSmithKline plc (ADR) (GSK): China to release blacklist for corporate bribery - Seeking Alpha | CHHHHHHHHHHHHHHINA | Scoop.it
GlaxoSmithKline plc (ADR) (GSK): China to release blacklist for corporate bribery
Seeking Alpha
Both GlaxoSmithKline (GSK +0.9%) and Danone SA (DANOY +1.5%) have been variously accused in China. Sent to 9,032 people ...
more...
No comment yet.
Rescooped by Sophie Webb from Market Research Report || Company Profile
Scoop.it!

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets | Market Research Reports

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets | Market Research Reports | CHHHHHHHHHHHHHHINA | Scoop.it

Aarkstore.com announces, a new market research report is available in its vast collection:

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

http://www.aarkstore.com/reports/China-Healthcare-Reform-and-Its-Impact-on-IVD-Medical-Device-and-Pharmaceutical-Markets-188840.html

 

China's rapid economic development and the numerous steps of reform undertaken by the Chinese central government since 1997 have had clear and observable effects upon China's total healthcare services market and its product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, which includes increased funding to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers? Kalorama analyst Emil Salazar focuses on these questions and more.

The report contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:

Statistics on Chinese Hospitals, Community Health Centers and Clinics
Top and Bottom City Markets for Urban Healthcare
Top and Bottom Rural Regions
Challenges for Foreign-Owned MNCs in China
Government Healthcare Spending
Foreign-Invested Manufacturing Enterprises in China
Share of Government Funded Healthcare vs. Out of Pocket
Domestic Healthcare Industries
Population and Age Statistics
Incidence Rates for Infectious Diseases
Cancer Rates in China
Regulation of Drugs and Devices in China
U.S. Product Exports to China
Key Analyst Conclusions

In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report provides data for business planning. It also takes a look at the status and forecast of the three key healthcare markets in China:

The Chinese Market for IVD products
Regional Breakout of the Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
The Chinese Market for Medical Device Products
Regional Breakout of the Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
Segment Breakout of the Chinese Medical Device Market(Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
The Chinese Market for Pharmaceutical Products
Regional Breakout of the Pharmaceutical Market(Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
Segment Breakout of the Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)

 

Table of Contents :

 

CHAPTER ONE: EXECUTIVE SUMMARY

Healthcare in China
Healthcare Reform and Market Impact
Rural Healthcare Market in Era of Reform
Urban Healthcare Market in Era of Reform
China’s IVD Market in an Era of Reform
China’s Medical Devices Market in an Era of Reform
China’s Pharmaceuticals Market in an Era of Reform
Major Findings

CHAPTER TWO: HEALTHCARE IN CHINA - PRIMARY INDICATORS AND A NEED FOR REFORM

Introduction
Barefoot Doctors and the Rural Cooperative Medical Scheme (RCMS)
China’s Economic Reform Impacts Healthcare
New Rural Cooperative Medical Scheme (NRCMS) and Government Recommitment to Reform
China on the Eve of Contemporary Healthcare Reform

More Related Reports :

  Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

  Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

  Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics

  Markets for Electrostimulation Devices (Neurostimulation, Cardiac Rhythm Management, Fracture Healing and Others)

  Medical Imaging Markets: Contrast Agents

  The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

  What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

  World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)

  The World Market for Veterinary Diagnostics

  The Market for Mobile Medical Apps

  Consumer Testing and The Future of DTC Genetic Testing

  The Global Market for Medical Devices, 3rd. Edition

  The World Market for Over The Counter (OTC) Drugs

RSS Link ... http://www.aarkstore.com/feeds/kalorama.xml

For More details about above & other Reports plz contact :

Vina

Aarkstore.com

Contact: Marketing team

Mob.No.918149852585

Email: enquiry@aarkstore.com

URL: http://www.aarkstore.com/

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstore

You can also request for sample page of above mention reports on sample@aarkstore.com

 

 


Via Vina T
more...
No comment yet.
Rescooped by Sophie Webb from BUSS4 China
Scoop.it!

KFC's Big Bucket of Problems in China

KFC's Big Bucket of Problems in China | CHHHHHHHHHHHHHHINA | Scoop.it
Yum! Brands optimism about a fourth-quarter recovery for KFC in China seems to have been premature

Via tutor2u
more...
Richard Smith's curator insight, December 29, 2013 3:13 PM

Originally a success story but now encountering some problems

Tiffany Li's curator insight, April 24, 2014 3:38 PM

KFC was predicting that the decrease in sales of KFC would turn around in the summer 2013. Sadly, they were wrong. KFC's profit has been down 68%. A decrease sales leads to a decrease in aggregate demand because people are wanting to buy less which would also lead to a decrease in GDP and price level.

Scooped by Sophie Webb
Scoop.it!

GSK China case raises foreign fears

James Kynge, principal of China Confidential, assesses the concerns of foreign companies in China about the government's crackdown on corruption, highlighted...
more...
No comment yet.
Scooped by Sophie Webb
Scoop.it!

Inside Story: Medicine and Drugs in China

Follow us on TWITTER: http://twitter.com/cnforbiddennews Like us on FACEBOOK: http://www.facebook.com/chinaforbiddennews A leading global pharmaceutical comp...
more...
No comment yet.
Scooped by Sophie Webb
Scoop.it!

GlaxoSmithKline warns of hit from China corruption case - economy

The boss of British drugmaker GlaxoSmithKline has said a "shameful" corruption scandal in... euronews, the most watched news channel in Europe Subscribe for ...
more...
No comment yet.